Abstract:Bacterial antimicrobial resistance (AMR) driven by the abuse of antibiotics is a global highlight challenge, calling for a rapid, economical and generalizable bacterial detection technology. Here, in case of urinary tract infections (UTIs), a naked-eye, antibody-free and multi-functional bacterial assessment platform was designed, which consisted of concanavalin A modified gold nanoparticles (ConA-AuNPs), vancomycin modified gold nanoparticles (Van-AuNPs), and polymyxin B modified Prussian blue nanoparticles (PMB-PBNPs). Based on the fast agglutination of bacterial cells induced by concanavalin A, ConA-AuNPs could aggregate on bacterial cells of Escherichia coli and Staphylococcus aureus , resulting in a visible color change due to alteration of surface plasmon resonance properties within 30 min. Besides, due to the different affinity of vancomycin and polymyxin B to bacteria, Van-AuNPs preferred to bind to Gram-positive bacteria, generating colorimetric response within 2–3 h; while PMB-PBNPs could be reduced colourless Prussian white (PW) by the prior Gram-negative bacterial metabolization in contrast to Gram-positive bacterial metabolization within 4–6 h. Combining our platform with antibiotics, the minimum inhibitory concentration of bacteria could be determined within 4–8 h, which was proved by incubating Escherichia coli and Staphylococcus aureus with various antibiotics. The feasibility was verified by clinical samples, which was consistent with the classical clinical test within only 1/48 of the process timing. Therefore, this colorimetric nanoplatform orderly realized the rapid detection, species identification (Gram-positive and Gram-negative), and susceptibility evaluation of bacteria, satisfying multiple needs from timely clinical diagnosis to accurate medication guidance.

Functionalized arrays of Raman-enhancing nanoparticles for capture and culture-free analysis of bacteria in human blood

Self-assembled Plasmonic Nanoarrays for Enhanced Bacterial Identification and Discrimination.

Cu/Ag Nanoparticle-Based Surface-Enhanced Raman Scattering Substrates for Label-Free Bacterial Detection

Rapid Identification and Monitoring of Multiple Bacterial Infections Using Printed Nanoarrays

Vancomycin-dendrimer Based Multivalent Magnetic Separation Nanoplatforms Combined with Multiplex Quantitative PCR Assay for Detecting Pathogenic Bacteria in Human Blood.

Combining Fluorescent Probes and Biofunctional Magnetic Nanoparticles for Rapid Detection of Bacteria in Human Blood

SERS-active Au@Ag core-shell nanorod (Au@AgNR) tags for ultrasensitive bacteria detection and antibiotic-susceptibility testing

Highly sensitive SERS nanoplatform based on aptamer and vancomycin for detection of S. aureus and its clinical application

SERS-encoded nanocomposites for dual pathogen bioassay

Nanoparticles-based Culture-free Method for Rapid and Sensitive Detection of Staphylococcus Aureus in Bloodstream Infections

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays.

Core-Shell Nanorod Columnar Array Combined with Gold Nanoplate-Nanosphere Assemblies Enable Powerful in Situ SERS Detection of Bacteria.

Wide-Range, Rapid, and Specific Identification of Pathogenic Bacteria by Surface-Enhanced Raman Spectroscopy

Multifunctional Nanoplatform for Dual-Mode Sensitive Detection of Pathogenic Bacteria and the Real-Time Bacteria Inactivation

Multifunctional AU Nano-Bridged Nanogap Probes As Icp-Ms/Sers Dual-Signal Tags and Signal Amplifiers for Bacteria Discriminating, Quantitative Detecting and Photothermal Bactericidal Activity

Rapid Enrichment and SERS Differentiation of Various Bacteria in Skin Interstitial Fluid by 4-Mpba-aunps-functionalized Hydrogel Microneedles

Point-of-Care Testing of Pathogenic Bacteria at the Single-Colony Level via Gas Pressure Readout Using Aptamer-Coated Magnetic CuFe 2 O 4 and Vancomycin-Capped Platinum Nanoparticles.

Colorimetric and Test Stripe-Based Assay of Bacteria by Using Vancomycin-Modified Gold Nanoparticles

A simple and rapid strategy for monitoring vancomycin concentration in serum using a multicolor immunosensor based on the ratio of gold nanobipyramids and a product of cetyltrimethylammonium bromide-blue oxide of 3,3',5,5'-tetramethylbenzidine interaction

Rapid, direct, visualized and antibody-free bacterial detection with extra species identification and susceptibility evaluation capabilities

Dual-Recognition Förster Resonance Energy Transfer Based Platform for One-Step Sensitive Detection of Pathogenic Bacteria Using Fluorescent Vancomycin-Gold Nanoclusters and Aptamer-Gold Nanoparticles.